Victory Capital Management Inc. Has $39.33 Million Holdings in Milacron Holdings Corp (MCRN)

Share on StockTwits

Victory Capital Management Inc. boosted its holdings in shares of Milacron Holdings Corp (NYSE:MCRN) by 14.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,474,029 shares of the industrial products company’s stock after purchasing an additional 433,282 shares during the period. Victory Capital Management Inc.’s holdings in Milacron were worth $39,326,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Meeder Asset Management Inc. raised its position in Milacron by 54.0% in the 4th quarter. Meeder Asset Management Inc. now owns 2,312 shares of the industrial products company’s stock worth $28,000 after purchasing an additional 811 shares during the last quarter. Advisory Services Network LLC raised its position in Milacron by 998.8% in the 4th quarter. Advisory Services Network LLC now owns 4,395 shares of the industrial products company’s stock worth $52,000 after purchasing an additional 3,995 shares during the last quarter. Oppenheimer Asset Management Inc. bought a new position in Milacron in the 4th quarter worth approximately $61,000. Quantamental Technologies LLC bought a new position in Milacron in the 4th quarter worth approximately $78,000. Finally, Great West Life Assurance Co. Can raised its position in Milacron by 77.8% in the 4th quarter. Great West Life Assurance Co. Can now owns 8,713 shares of the industrial products company’s stock worth $100,000 after purchasing an additional 3,813 shares during the last quarter. Hedge funds and other institutional investors own 98.20% of the company’s stock.

MCRN stock traded up $0.20 during trading on Thursday, hitting $13.45. The company had a trading volume of 11,193 shares, compared to its average volume of 530,462. Milacron Holdings Corp has a 12 month low of $11.11 and a 12 month high of $22.09. The stock has a market capitalization of $916.52 million, a PE ratio of 7.46, a price-to-earnings-growth ratio of 1.87 and a beta of 1.55.

Milacron (NYSE:MCRN) last released its earnings results on Tuesday, April 30th. The industrial products company reported $0.27 EPS for the quarter, topping analysts’ consensus estimates of $0.26 by $0.01. Milacron had a net margin of 2.91% and a negative return on equity of 74.38%. The firm had revenue of $248.70 million during the quarter, compared to analyst estimates of $279.52 million. During the same quarter in the previous year, the business earned $0.40 EPS. The business’s quarterly revenue was down 13.9% compared to the same quarter last year. On average, equities research analysts anticipate that Milacron Holdings Corp will post 1.39 earnings per share for the current year.

In other Milacron news, VP Hugh C. Odonnell sold 3,021 shares of Milacron stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.03, for a total transaction of $42,384.63. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Ling An-Heid sold 5,855 shares of Milacron stock in a transaction on Monday, March 4th. The stock was sold at an average price of $14.03, for a total transaction of $82,145.65. The disclosure for this sale can be found here. 3.40% of the stock is currently owned by insiders.

Several research analysts recently weighed in on MCRN shares. Robert W. Baird dropped their price objective on shares of Milacron from $24.00 to $21.00 and set an “outperform” rating for the company in a research report on Thursday, February 21st. ValuEngine upgraded shares of Milacron from a “strong sell” rating to a “sell” rating in a research report on Friday, April 19th. Finally, Zacks Investment Research cut shares of Milacron from a “hold” rating to a “strong sell” rating in a research report on Monday, March 11th. Two investment analysts have rated the stock with a sell rating and two have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $19.00.

TRADEMARK VIOLATION WARNING: This piece was reported by Zolmax and is the property of of Zolmax. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://zolmax.com/investing/victory-capital-management-inc-has-39-33-million-holdings-in-milacron-holdings-corp-mcrn/3085907.html.

Milacron Profile

Milacron Holdings Corp. manufactures, distributes, and services engineered and customized systems within the plastic technology and processing industry in the United States and internationally. The company operates through three segments: Advanced Plastic Processing Technologies (APPT), Melt Delivery and Control Systems (MDCS), and Fluid Technologies (Fluids).

Further Reading: How to trade on quiet period expirations

Want to see what other hedge funds are holding MCRN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Milacron Holdings Corp (NYSE:MCRN).

Institutional Ownership by Quarter for Milacron (NYSE:MCRN)

Receive News & Ratings for Milacron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milacron and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Hillsdale Investment Management Inc. Purchases 500 Shares of United Technologies Co.
Hillsdale Investment Management Inc. Purchases 500 Shares of United Technologies Co.
Hillsdale Investment Management Inc. Buys 300 Shares of Best Buy Co Inc
Hillsdale Investment Management Inc. Buys 300 Shares of Best Buy Co Inc
Gattaca  Trading Down 1.9%
Gattaca Trading Down 1.9%
RIGHTMOVE PLC/ADR  Trading Up 0.1%
RIGHTMOVE PLC/ADR Trading Up 0.1%
Luceco  Trading Down 2.9%
Luceco Trading Down 2.9%
Cell MedX  Shares Up 2.6%
Cell MedX Shares Up 2.6%


 
© 2006-2019 Zolmax.